Abstract
The expansion of hematopoietic stem/progenitor cells (HSPCs) from umbilical cord blood (UCB) with the support of microencapsulated osteoblasts under hypoxia environment was investigated. The expansion of HSPCs was evaluated through the total number of UCB mononuclear cells (MNCs) produced, their repopulating potential with the colony-forming unit assay (CFU-Cs) and CD34+ phenotypic analysis with flow cytometry. At the end of 7 days of culture, the UCB-MNCs, CFU-Cs and CD34+ cells had achieved 18.7 ± 1.6, 11.6 ± 0.9 and 23.4 ± 2-fold expansions, respectively, in the test groups. These were significantly different from those in control groups. Microencapsulated osteoblasts under hypoxia conditions had therefore a significant effect on the expansion potential of HSPCs in vitro.
Similar content being viewed by others
References
Arai F (2005) Regulation of hematopoiesis by the osteoblastic niche. Clin Calcium 15:73–79
Barker JN, Wagner JE (2003) Umbilical cord blood transplantation: current practice and future innovations. Crit Rev Oncol Hematol 48:35–43
Calvi LM, Adams GB, Weibrecht KW et al (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:842–846
Conneally E, Cashman J, Petzer A et al (1997) Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA 94:9836–9841
Dellatore SM, Garcia AS, Miller WM (2008) Mimicking stem cell niches to increase stem cell expansion. Curr Opin Biotechnol 19(5):534–540
Derubeis AR, Cancedda R (1998) The role of osteoblasts in the hematopoietic microenvironment. Stem Cells 16(1):7–15
Fujimoto N, Fujita S, Tsuji T et al (2007) Microencapsulated feeder cells as a source of soluble factors for expansion of CD34(+) hematopoietic stem cells. Biomaterials 28(32):4795–4805
Gluckman E, Rocha V, Arcese W et al (2004) Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 32:97–407
Laughlin MJ, Barker J, Bambach B et al (2001) Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344:1815–1822
Lemischka IR, Moore KA (2003) Stem cells: interactive niches. Nature 425:778–779
Liu Y, Liu T, Ma X et al (2008) Effects of encapsulated rabbit mesenchymal stem cells on ex vivo expansion of human umbilical cord blood hematopoietic stem/progenitor cells. J Microencapsul 4:1–13
Pecora AL, Stiff P, Jennis A et al (2000) Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 25:797–799
Phinney DG, Isakova I (2005) Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des 11(10):1255–1265
Shpall EJ, Quinones R, Giller R et al (2002) Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 8:368–376
Song KD, Liu TQ, Li XQ et al (2007) Three-dimensional expansion: in suspension culture of SD rat’s osteoblasts in a rotating wall vessel bioreactor. Biomed Environ Sci 20:91–98
Taichman RS, Reilly MJ, Emerson SG (2000) The hematopoietic microenvironment: osteoblasts and the hematopoietic microenvironment. Hematology 4(5):421–426
Zandstra PW, Nagy A (2001) Stem cell bioengineering. Annu Rev Biomed Eng 3:275–305
Zhang J, Niu C, Ye L et al (2003) Identification of the hematopoietic stem cell niche and control of the niche size. Nature 425:386–841
Acknowledgments
This work was supported by grants from the National Natural Sciences Foundation of China (30700181) and the New teacher foundation of Ministry of Education (20070141055).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Song, K., Zhao, G., Liu, T. et al. Effective expansion of umbilical cord blood hematopoietic stem/progenitor cells by regulation of microencapsulated osteoblasts under hypoxic condition. Biotechnol Lett 31, 923–928 (2009). https://doi.org/10.1007/s10529-009-9961-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-009-9961-0